Definium公布LSD药物后期试验成功 (DFTX:NASDAQ)
· seekingalpha.com
Definium Therapeutics (DFTX)股价上涨，因其基于LSD的精神病药物治疗焦虑症在后期试验中取得成功。在此阅读更多。
Definium Therapeutics (DFTX) on Wednesday announced that a late-stage trial for DT120, its LSD-based psychiatric treatment, reached the main goal in patients wi...